MRNA — candidate.roundup
Update
MRNA — candidate.roundup
Reason: MRNA cooled this cycle rather than extending further - 30D down to +126.12% (was +158.71%), 1-year change +467.03% (was +499.46%), alpha +450.82 (was +480.81) - still the desk's most extreme number, magnitude still unaccounted for by any on-file receipt. AMGN deteriorated sharply: RSI fell to 31.5 (was 62.5, now near-oversold), 7D -13.7%, 1-year change down to +33.47% (was +56.1%), alpha to +17.25 (was +37.45), and its cushion above its 200-day thinned to +5% (was +23.4%). VRTX cooled across every window (1-year change +29.71%, was +37.59%). TMO held roughly steady.
Price/RSI Table
| Stock | Price | 7D | 30D | 52wkHi | RSI | Status | Action |
|---|---|---|---|---|---|---|---|
| MRNA | $143.97 | -1.09% | +126.12% | -18.50% | 61.2 | 🟢 Extended | 🔍 Watch/Research |
| VRTX | $515.44 | -5.62% | -1.96% | -8.00% | 44.0 | 🟢 Pullback entry | 🔒 Hold |
| TMO | $609.82 | -0.65% | +1.13% | -5.75% | 54.8 | 🟢 Pullback entry | 🔒 Hold |
| AMGN | $377.35 | -13.70% | -9.33% | -15.59% | 31.5 | 🟡 Neutral | 🔍 Watch |
What Changed Since 2026-09-04
- MRNA cooled rather than extending: 30D +126.12% (was +158.71%), 1-year change +467.03% (was +499.46%), alpha +450.82 (was +480.81) - still the sharpest number on the desk. No fresher news receipt was pulled this cycle beyond the previously-noted litigation-settlement item; the magnitude remains unaccounted for.
- AMGN is this cycle's new deterioration: RSI fell from 62.5 to 31.5 (near-oversold), 7D -13.7%, 1-year change down to +33.47% (was +56.1%), alpha to +17.25 (was +37.45), and its 200-day cushion thinned to +5% (was +23.4%). AMGN's own news receipt is fetched 2026-09-09 (one day short of this cycle's freshness bar) and lists a 2026-09-09 headline referencing Amgen dropping pipeline candidate AMG 513 alongside Q2 results - noted but not treated as a confirmed cause here since the receipt predates the required window; research/stock-events shows no dated event this week for AMGN. Cause otherwise unknown for the week's decline.
- VRTX cooled across every window: 1-year change +29.71% (was +37.59%), alpha +13.49 (was +18.93).
- TMO held roughly steady: 1-year change +24.1% (was +25.39%), alpha +7.88 (was +6.74, essentially flat).
Sources
- Tape data (price/RSI/SMA/returns/1-year change/1-year alpha): pre-computed summaries as of the 2026-09-11 close — biotech (MRNA, VRTX, TMO) and biotech-scan (AMGN, tracked outside the core biotech watchlist).
- News check (AMGN): latest (fetched 2026-09-09, one day short of this cycle's freshness bar; no fresher pull found).
- Prior-cycle comparison: 2026-09-04-biotech.
Related
10 eventsNo direct external sources are attached to this read.